A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

NCT01186744 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
666
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer